India's epidemic is out of control and vaccine supply is insufficient

India has the world's largest vaccine production base, and major international pharmaceutical companies have found new coronavirus vaccines in India. India also has vaccine development capabilities. India has previously approved two vaccines for emergency use, one of which It is a model developed by India itself, and the other is an OEM product for the UK. In view of the spread of the global epidemic, the United Nations has established a vaccine distribution mechanism through which vaccines are distributed to countries and regions around the world. India has actively joined the vaccine distribution mechanism. India supplies vaccines developed by the United Kingdom.

According to Indian media reports, India’s largest vaccine manufacturer has publicly announced that India will not be able to export vaccines until the end of 2021. India will give priority to the supply of vaccines used in India. For the export of vaccines, Indian manufacturers and the Indian government already have After the game, exporters are also involved. Regarding the Indian vaccine manufacturer's claim that it can export vaccines before the end of the year, the outside world still expresses doubts, because it depends on the development of this wave of epidemic in India. If the epidemic in India does not improve, India will obviously not be able to export more vaccine products. According to estimates, based on current levels, it will take three years for India to achieve vaccination of 75% of its population.

The FDA has also urgently approved the Janssen vaccine containing hydroxypropyl beta-cyclodextrin (HPBCD) for use against the new coronavirus.